Zurich Cantonal Bank’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Zurich Cantonal Bank’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,156	Closed	-$152K	–	2684
2020 Q4	$152K	Buy	+1,156	New	+$102K	﹤0.01%	2006

Zurich Cantonal Bank's EIDX Position: Q1 2021 in Review

Zurich Cantonal Bank sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 1,156 shares — an estimated $152K sold.

Zurich Cantonal Bank first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $152K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Zurich Cantonal Bank reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Zurich Cantonal Bank sold 1,156 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $152K.
Zurich Cantonal Bank first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Zurich Cantonal Bank's Eidos Therapeutics, Inc. Common Stock position peaked at $152K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Zurich Cantonal Bank's 13F filing for Q1 2021, filed 3 May 2021.